US District Courts grapple with novel legal issues relating to Chinese companies sued in U.S. for antitrust violations (Vitamin C and Magnesite cartel)

As the world economy grows increasingly interconnected, plaintiffs’ lawyers in the US are searching for ways to sue foreign companies in US courts for anticompetitive behavior. Several recent Sherman Act cases have been brought against consortiums of partially government owned Chinese companies alleging price-fixing activity that impacts US markets. The increasing willingness of plaintiffs’ lawyers to bring US antitrust lawsuits against Chinese companies may raise the interest of the Department of Justice and lead to future cartel investigations. Two recent cases illustrate this developing trend: In re Vitamin C Antitrust Litigation, 584 F. Supp. 2d 546 (E.D.N.Y. 2008) (hereinafter “Vitamin C”) and Animal Science Products, Inc. v. China National Metals & Minerals Import & Export

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Sheppard Mullin (San Francisco)
  • Paul Hastings (Washington)

Quotation

Michael Cohen, Jeremy Evans, US District Courts grapple with novel legal issues relating to Chinese companies sued in U.S. for antitrust violations (Vitamin C and Magnesite cartel), 30 December 2008, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 74785

Visites 58

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues